Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Palexia

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 582Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    West-Ward Pharms’s Generics Tapentadol Receives Approval in US
    West-Ward Pharms’s Generics Tapentadol Receives Approval in US

    13 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206418

    FDA
    13 Feb 2026
    Share Share
    Hikma’s Generics Tapentadol HCl Receives Approval in US
    Hikma’s Generics Tapentadol HCl Receives Approval in US

    10 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205057

    FDA
    10 Feb 2026
    Share Share
    Humanwell’s Generics Tapentadol HCl Receives Approval in US
    Humanwell’s Generics Tapentadol HCl Receives Approval in US

    27 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214378

    FDA
    27 Jan 2026
    Share Share
    Novitium Pharma’s Generics Tapentadol HCl Receives Approval in US
    Novitium Pharma’s Generics Tapentadol HCl Receives Approval in US

    26 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219119

    FDA
    26 Jan 2026
    Share Share
    Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa
    Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa

    22 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183693&sid=1

    PHARMABIZ
    22 Jan 2026
    Share Share
    Delhi DCA Warns Chemists on Misuse of Pregabalin, Tapentadol
    Delhi DCA Warns Chemists on Misuse of Pregabalin, Tapentadol

    19 Aug 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=180763&sid=1

    PHARMABIZ
    19 Aug 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.